<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The objective of this study was to investigate whether <z:hpo ids='HP_0002045'>hypothermia</z:hpo> would suppress secondary damage in the <z:hpo ids='HP_0011010'>chronic</z:hpo> postischemic stage, in terms of <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> excitotoxicity </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Gerbils underwent 5 minutes of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> via bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Seven groups were studied, as follows: 1) <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> without treatment group; 2) intraischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> group; 3) postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> group (32 degrees C for 4 h); 4) MK-801 treatment group (2 mg/kg, every other day for 1 mo); 5) postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> with MK-801 treatment for 1 week group (2 mg/kg, every other day); 6) postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> with MK-801 treatment for 1 month group (2 mg/kg, every other day); and 7) sham-treated control group </plain></SENT>
<SENT sid="3" pm="."><plain>One month after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, histological changes in hippocampal CA1 neurons (assessed using <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin staining) and memory function (assessed using an eight-arm radial maze) were studied </plain></SENT>
<SENT sid="4" pm="."><plain>Extracellular <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> concentrations were monitored by microdialysis during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Staining of microglia was performed 1 week and 1 month after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: MK-801 alone, postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> alone, and postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> with MK-801 treatment for 1 week failed to prevent ischemic neuronal damage and memory function decreases 1 month after the insult (P &lt; 0.05 versus control) </plain></SENT>
<SENT sid="7" pm="."><plain>However, the postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> with MK-801 treatment for 1 month group exhibited significant protective effects (not significant [P &gt; 0.05] compared with the control group) </plain></SENT>
<SENT sid="8" pm="."><plain>Extracellular <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> levels for the intraischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> group were significantly low, compared with the postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> group </plain></SENT>
<SENT sid="9" pm="."><plain>There was no microglial activation in the postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> at 1 week and 1 month after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> groups </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Postischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and long-term intermittent administration of MK-801 demonstrated significant neuronal protection, indicating that long-term glutamatergic activation, with changes in <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> receptors, plays a role in neuronal damage in the <z:hpo ids='HP_0011010'>chronic</z:hpo> postischemic stage </plain></SENT>
</text></document>